ArticleAnnals of hematology2021
Compassionate use of glasdegib in combination with low-dose cytarabine for relapsed, refractory acute myeloid leukemia or high-risk myelodysplastic syndrome.
Márcio Tavares et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it